TransAlta Corporation Ordinary Shares (TAC)

Property Plant Equipment Net

$5.78B

Quarterly · Period ending: · CAD

TAC logo

TAC Property Plant Equipment Net

Latest reported$5.78B CAD
TAC Quarterly PP&E (Net) · CAD ($4.54B → $5.78B)
High-resolution chart · PNG

TAC property plant equipment net history

Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.

TransAlta Corporation Ordinary Shares Property Plant Equipment Net — Quarterly (CAD)
Period endingProperty Plant Equipment Net (CAD)
5,782,000,000
5,805,965,475
5,795,000,000
5,862,000,000
5,913,000,000
6,038,000,000
6,170,000,000
5,660,000,000
5,731,000,000
5,777,000,000
5,831,000,000
5,797,000,000
5,791,000,000
5,812,000,000
5,722,000,000
5,390,000,000
5,241,000,000
5,284,000,000
5,415,000,000
5,290,000,000
5,716,000,000
5,790,000,000
5,963,000,000
6,036,000,000
6,087,000,000
6,220,000,000
6,353,000,000
5,979,000,000
6,117,000,000
6,110,000,000
6,164,000,000
6,201,000,000
6,359,000,000
6,469,000,000
6,578,000,000
6,654,000,000
6,704,000,000
6,811,000,000
6,824,000,000
6,970,000,000
6,948,000,000
7,030,000,000
7,173,000,000
7,208,000,000
7,226,000,000
7,290,000,000
7,238,000,000
7,162,000,000
7,134,000,000
7,171,000,000
7,193,000,000
7,138,000,000
7,116,000,000
7,078,000,000
7,044,000,000
6,966,000,000
6,891,000,000
7,257,000,000
7,288,000,000
7,296,000,000
7,243,000,000
7,234,000,000
7,577,000,000
7,789,000,000
7,742,000,000
7,536,000,000
7,578,000,000
6,251,000,000
6,170,000,000
6,104,000,000
6,021,126,761
5,620,608,899
5,406,065,540
5,257,689,538
5,117,299,633
5,023,300,209
5,002,399,575
4,994,499,539
5,041,900,047
5,390,600,201
5,447,200,223
5,507,099,486
5,545,499,477
5,572,900,116
5,710,899,718
5,955,800,484
6,244,400,048
6,243,310,912
6,414,519,369
6,350,798,745
6,316,900,683
6,919,000,295
6,879,629,718
7,119,817,498
6,035,100,724
6,017,776,337
5,791,408,213
6,272,514,838
6,124,099,013
5,725,954,022
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.